Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Cholesterol Medicines:Side Effects May Outweigh Benefits

MEDIA RELEASE                                                                         

3 JUNE 2013

Cholesterol-lowering Medicines In Elderly People: Side Effects May Outweigh Benefits

At least four in every ten Australians over the age of 65 are taking a cholesterol-lowering medicine, with statins such as atorvastatin, simvastatin and rosuvastatin the most commonly prescribed. However, according to an article in the June edition of Australian Prescriber, the risk of side effects in frail elderly people may outweigh the benefits of continuing on a statin.

Associate Professor Sarah Hilmer and Dr Danijela Gnjidic of the University of Sydney say that statins lower the chance of a heart attack or death in older people who have already had a heart attack. However, the benefit of statins in older people who do not already have heart disease is less clear.

“Statins can cause side effects, and these are more likely in people aged over 70, especially those taking several other medicines,” write the authors.

“Muscle pain or muscle damage are the most common side effects that cause people to stop treatment. Statins can also cause liver problems,” said the authors.

“Statins have also been found to contribute to memory loss or confusion in some people. This side effect may be reversed when statins are stopped.”

NPS MedicineWise clinical adviser Dr Philippa Binns says that it is important that people who have questions or concerns about their medicines talk to their doctor to get personalised advice.

“The benefits of a medicine must always be balanced against the harms,” says Dr Binns.

“It’s also natural that your priorities and your ability to tolerate a medicine may change over time. What’s important is that you don’t stop taking your medicine without consulting your doctor.”

To read the full article and others visit www.australianprescriber.com

People with questions about their medicine can call the NPS Medicines Line (1300 MEDICINE or 1300 633 424), Monday to Friday 9am to 5pm AEST.

ENDS.

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Scoop Business: PayPal Stops Processing Mega Payments; NZX Listing Still On

PayPal has ceased processing payments for Mega, the file storage and encryption firm looking to join the New Zealand stock market via a reverse listing of TRS Investments, amid claims it is not a legitimate cloud storage service. More>>

ALSO:

Housing Policy: Auckland Densification As Popular As Ebola, English Says

Finance Minister Bill English said calls by the Reserve Bank Governor for more densification in Auckland’s housing were “about as popular in parts of Auckland as Ebola” would be. More>>

ALSO:

Crown Accounts: NZ Government Deficit Smaller Than Expected In First Half

The New Zealand government's operating deficit was smaller than expected in the first six months of the financial year, as the consumption and corporate tax take rose ahead of forecast in December, having lagged estimates in previous months. More>>

ALSO:

Fruit & Veg Crackdown: Auckland Fruit Fly Find Under Investigation

The Ministry for Primary Industries (MPI) is investigating a find of a single male Queensland fruit fly in a surveillance trap in the Auckland suburb of Grey Lynn... MPI has placed legal controls on the movement of fruit and some vegetables outside of a defined circular area which extends 1.5km from where the fly was trapped in Grey Lynn. More>>

ALSO:

Scoop Business: Westpac NZ Reaches $2.97M Swaps Settlement

Westpac Banking Corp’s New Zealand unit has agreed to pay $2.97 million in a settlement with the Commerce Commission over the way the bank sold interest rate swaps to farmers between 2005 and 2012. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news